Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Cash on Hand and in U.S. Banks
QFRTCASH385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
65,271.00
Year-over-Year Change
-3.02%
Date Range
10/1/2000 - 4/1/2025
Summary
This trend tracks the total cash reserves held by U.S. pharmaceutical and medicine corporations in domestic banks. It provides critical insight into the financial liquidity and strategic cash management of a key sector in the American economy.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The metric represents the aggregate liquid financial resources available to pharmaceutical companies, reflecting their financial health and potential for investment, research, or strategic acquisitions. Economists and investors use this data to assess the sector's financial resilience and potential economic impact.
Methodology
Data is collected through quarterly financial reporting by corporations in the pharmaceutical and medicine manufacturing sector, compiled and standardized by the U.S. Federal Reserve.
Historical Context
This trend is used to analyze corporate financial strategies, potential investment cycles, and sectoral economic performance in the healthcare and pharmaceutical industries.
Key Facts
- Represents total liquid assets for U.S. pharmaceutical corporations
- Quarterly data provides snapshot of sector's financial health
- Indicates potential for R&D investment and strategic spending
FAQs
Q: What does this trend indicate about pharmaceutical companies?
A: It shows the total cash reserves available to pharmaceutical firms, reflecting their financial strength and potential for investment or expansion.
Q: How often is this data updated?
A: The data is typically updated on a quarterly basis, providing a current view of the sector's financial position.
Q: Why are cash reserves important for pharmaceutical companies?
A: Cash reserves enable companies to fund research and development, make strategic acquisitions, and maintain financial stability during market fluctuations.
Q: How do investors use this information?
A: Investors analyze these cash reserves to assess a company's financial health, potential for growth, and ability to weather economic challenges.
Q: What limitations exist in this data?
A: The trend provides an aggregate view and may not capture individual company variations or specific financial strategies.
Related Trends
Quarterly Financial Report: U.S. Corporations: All Other Professional and Technical Services, Except Legal Services: Provision for Current and Deferred Domestic Income Taxes
QFRD114549USNO
Quarterly Financial Report: U.S. Corporations: Aerospace Products and Parts: Total Liabilities and Stockholders' Equity
QFR328386USNO
Quarterly Financial Report: U.S. Corporations: All Other Information: All Other Noncurrent Liabilities
QFR320519USNO
Quarterly Financial Report: U.S. Corporations: Computer and Electronic Products: All Other Current Liabilities
QFRD315COMUSNO
Quarterly Financial Report: U.S. Corporations: All Mining: Net Working Capital
QFRNWCMINUSNO
Quarterly Financial Report: U.S. Corporations: Motor Vehicles and Parts: Long-Term Debt, Due in More Than 1 Year: Loans from Banks
QFR316376USNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Cash on Hand and in U.S. Banks [QFRTCASH385USNO], retrieved from FRED.
Last Checked: 8/1/2025